LEXINGTON, Mass.--(BUSINESS WIRE)--KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics ® discovery platform, and CTMC, ...

Scientists provide a comprehensive overview of the evolution and potential of TIL therapy. They describe its development and highlight its transformative potential. The recent U.S. Food and Drug ...

Cancer immunotherapy has revolutionized treatment for many patients, but significant challenges remain in predicting who will respond to these life-saving treatments. A new comprehensive review ...

Atypical lymphocytes are types of white blood cells that a person’s immune system produces. They help fight infections and diseases. High levels of atypical lymphocytes may indicate certain health ...

Data from 29 studies covering brain, nasopharyngeal, oropharyngeal, esophageal, non–small cell lung, hepatocarcinoma, cervical, pancreatic, rectal cancers, and soft tissue sarcoma were analyzed.

Lymphocyte-depleted Hodgkin’s lymphoma (LDHL) is a rare subtype of Hodgkin’s lymphoma, a cancer that develops in the lymphatic system. Hodgkin’s lymphoma (HL) is an uncommon cancer of the lymphatic ...

High neutrophils and low lymphocytes can mean your body is under severe stress or fighting an infection. The neutrophil-to-lymphocyte ratio (NLR) helps doctors understand how sick you are and what ...

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: Results from a large single-centre cohort analysis. Model is adjusted for age, ...